Delivery Order SPE2DR25D1052-SPE2DR26F6DW8
Award Date 3/10/26
Potential Completion Date 3/11/26
Potential Value $3.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Repatha 140 mg/ml SureClick, with a ceiling value of $21,817.11. The order is placed under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order has a...
- The Defense Logistics Agency issued a $29,091.48 delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for Repatha 140 mg/ml SureClick pharmaceutical supply. Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 26, 2026, and is priced on a firm fixed-price basis. The delivery order was issued under the parent Indefinite Delivery Contract held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, a comprehensive global...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 9, 2026, for Repatha 140 mg/ml SureClick with a ceiling value of $3,316.65. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $1,804.96 worth of Repatha 140 mg/mL SureClick medication. The contract has a completion date of February 1, 2024 and was awarded on January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract with a...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for Repatha 140 mg/ml SureClick with a ceiling value of $7,998.37, under the DLA Troop Support Medical IDC (SPE2DX).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is March 6, 2026. The order is firm fixed price with no set-aside.</p>
- The Defense Logistics Agency issued a $7,346.14 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Repatha 140 mg/ml SureClick pharmaceutical product. The order was issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 3, 2026, for Repatha 140 mg/ml SureClick with a ceiling value of $2,107.24 and an ultimate completion date of March 4, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside applied.</p>
- The Defense Logistics Agency issued a $12,231.33 delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Repatha 140 mg/ml SureClick pharmaceutical supply. The order was placed under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which enables supply of pharmaceutical products and medical supplies across multiple therapeutic domains to military healthcare programs...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for Repatha 140 mg/ml SureClick, with a ceiling value of $1,462.37, under the DLA Troop Support Medical IDC (SPE2DX).</p> <p>Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with an ultimate completion date of March 5, 2026.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for Repatha 140 mg/ml SureClick with a ceiling value of $9,727.81. The order is placed under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026. Amerisourcebergen Drug Corp supplies a full range of pharmaceutical products and medical supplies to support military healthcare...
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6DW8Delivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 10, 2026, with a ceiling value of $3,193.38 for Repatha 140 mg/ml SureClick medication. Place of performance is Conshohocken, PA. Ultimate completion date is March 11, 2026. The order was issued under firm fixed-price pricing with no set-aside applied. AmerisourceBergen Drug Corp operates as a division of Cencora, Inc., a pharmaceutical distributor serving federal medical procurement needs. The company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, supporting comprehensive pharmaceutical supply to military healthcare programs worldwide.
Generated 6/8/26, 10:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 3/9/26 |